Remove Documentation Remove Download Remove FDA
article thumbnail

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases.

FDA 105
article thumbnail

Whole genome sequencing and analysis of live biotherapeutic products

European Pharmaceutical Review

The US Food and Drug Administration (FDA) created live biotherapeutic products (LBP) as a new category in the 2012 guidelines. EMA and FDA have given prime importance to the whole genome sequence characterisation of the strain in the final product dossier. Download and read more now… .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is my Software a Medical Device? Use the Digital Health Policy Navigator

The FDA Law Blog

Baumhardt, Senior Medical Device Regulation Expert — With the explosion of health‑related software, many software developers are generating products with functionality that is subject to regulation by the Food and Drug Administration (FDA). Please check out FDA’s presentation on this very topic – Is My Product a Medical Device?

article thumbnail

How to use Pay Per Click Advertising to Reach HCPs in Pharma

Pharma Marketing Network

Conversion Rate: Tracks how many users complete a desired action, such as signing up for a webinar or downloading whitepapers. Using Google Display Network, LinkedIn, or eHealthCare Solutions , brands can: Show relevant ads to HCPs who viewed but didnt download resources. Avoiding misleading claims that exaggerate efficacy or safety.

article thumbnail

Apple adds medication tracking to iPhone and Apple Watch

pharmaphorum

Users can also use the built-in health records feature on the Health app to download current medications, said Ricky Bloomfield, a former director of mobile strategy at Duke University who joined Apple as clinical and health informatics lead in 2016 in a tweet.

article thumbnail

The Good, Bad, and Ugly side of 510(k)s—HP&M’s Early Experience with the eSTAR Template for 510(k)s: Part 2

The FDA Law Blog

Lack of compatibility with cloud-based document sharing. It must first be downloaded, revised, and uploaded back to the system. Creation of unnecessary documents. There is no option to reference a document that has already been attached elsewhere in the submission.

article thumbnail

FDA sketches a path for patient-focused drug development

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has released the fourth and final chapter in a series of guidance documents designed to support patient-focused drug development. The guidance also touched upon clinical trial design elements that must be explained, described, or rationalised to the FDA.

FDA 52